Lido Advisors, LLC Provention Bio, Inc. Transaction History

Lido Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.52 - $10.57 $9,943 - $23,254	-2,200 Reduced 12.02%	16,100 $170,000
Q1 2021 May 13, 2021	SELL	$10.12 - $19.45 $2,783 - $5,348	-275 Reduced 1.48%	18,300 $192,000
Q4 2020 Feb 08, 2021	SELL	$11.79 - $18.94 $12,674 - $20,360	-1,075 Reduced 5.47%	18,575 $314,000
Q2 2020 Aug 12, 2020	SELL	$7.81 - $17.0 $13,433 - $29,240	-1,720 Reduced 8.05%	19,650 $277,000
Q1 2020 May 13, 2020	SELL	$5.42 - $17.75 $94,850 - $310,625	-17,500 Reduced 45.02%	21,370 $197,000
Q4 2019 Feb 07, 2020	SELL	$5.84 - $14.9 $5,256 - $13,410	-900 Reduced 2.26%	38,870 $579,000
Q3 2019 Nov 12, 2019	BUY	$6.83 - $13.0 $69,802 - $132,860	10,220 Added 34.59%	39,770 $271,000
Q2 2019 Aug 14, 2019	BUY	$2.3 - $13.79 $6,324 - $37,922	2,750 Added 10.26%	29,550 $357,000
Q4 2018 Feb 14, 2019	BUY	$1.73 - $4.0 $46,364 - $107,200	26,800 New	26,800 $47,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.